Schistosomiasis vaccine development: progress and prospects.
about
Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infectionDNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge InfectionHuman antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum.Human IgG1 Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment.Invertebrate muscles: muscle specific genes and proteins.DNA vaccines against tropical parasitic diseases.Cross-reactivity of Schistosoma mansoni cytosolic superoxide dismutase, a protective vaccine candidate, with host superoxide dismutase and identification of parasite-specific B epitopes.Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage.Gastrointestinal complications of schistosomiasis.Proteomic analysis of Schistosoma mansoni cercarial secretions.Investigation of recombinant Schistosoma japonicum paramyosin fragments for immunogenicity and vaccine efficacy in mice.
P2860
Q27306926-6C444590-163C-4B7A-B370-CE80235A74E5Q28547011-0288C13F-FD55-4CC7-9D5A-625160F94211Q33245126-F6D03E66-09B1-4A19-8D4C-C4E71F654805Q33853821-36BA7905-D914-4685-8B1D-9D8140101091Q34145933-3DBB2BB5-D351-489E-8B63-1B5A70E184F2Q34301170-4EB4AD2D-284A-4062-8691-12104696B234Q35684066-220017F4-5EA4-476B-AA47-D8739E410C72Q36178999-2352B27A-7A1E-46E9-B6E9-99E6A338E2C8Q36238733-C5B9E17D-F92B-44A0-B541-50D21638F7BAQ37427225-28DAF9BD-7A5F-4897-AEE9-2B6F3B71F81AQ37523953-1FFF28CD-F692-46A7-82EA-2BD09228B05AQ43685664-F8947E14-A392-488D-8CBC-CEF34FA241DFQ46951966-B4357615-6065-471D-B47B-94C8A23FD26AQ54471472-E4B05259-6360-433A-90ED-D9F34335BF5A
P2860
Schistosomiasis vaccine development: progress and prospects.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Schistosomiasis vaccine development: progress and prospects.
@en
type
label
Schistosomiasis vaccine development: progress and prospects.
@en
prefLabel
Schistosomiasis vaccine development: progress and prospects.
@en
P2860
P1476
Schistosomiasis vaccine development: progress and prospects.
@en
P2093
Bergquist NR
P2860
P304
P356
10.1590/S0074-02761998000700013
P478
93 Suppl 1
P577
1998-01-01T00:00:00Z